Clinical Trials
89 trialsMicrobial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
Hospices Civils de Lyon
SERENTA
Rapamycin Holdings Inc.
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
University of Michigan Rogel Cancer Center
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
RAPA-4-PAF
University Hospital, Toulouse
iCaRe2
University of Nebraska
VitB1; FAP
Shanghai Zhongshan Hospital
SJFAMILY
St. Jude Children's Research Hospital
TUPELO
Recursion Pharmaceuticals Inc.
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
HonorHealth Research Institute
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NuView
Vanderbilt University Medical Center
LATA-IBD
Sahlgrenska University Hospital
RESTODIG
Assistance Publique Hopitaux De Marseille
DRACO
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
BHB-FAP
Abramson Cancer Center at Penn Medicine
Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
Instituto do Cancer do Estado de São Paulo
TESTIMONY
Odense University Hospital
Papillectomy
Azienda USL Reggio Emilia - IRCCS
COPDA
Western Sydney Local Health District
C2D2
Johns Hopkins University
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
Rapamycin Holdings Inc.
Sirolimus and Familial Adenomatous Polyposis (FAP)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lithium in FAP
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Pfizer
Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polyposis
Yonsei University
coldAPC
Universitätsklinikum Hamburg-Eppendorf
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
S.L.A. Pharma AG
ICED
Royal Marsden NHS Foundation Trust
adductomics
University of Copenhagen
FLUOFAP
University Medical Center Groningen
DARIAC
Hôpital Edouard Herriot
A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment
Peking Union Medical College Hospital
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
Janssen Research & Development, LLC
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
M.D. Anderson Cancer Center
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
National Cancer Institute (NCI)
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
National Cancer Institute (NCI)
Incidental Cancer in Familial Adenomatous Polyposis
Dr. Ersin Arslan Education and Training Hospital
KOPOF
Universitaire Ziekenhuizen KU Leuven
The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
Yonsei University
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Cancer Prevention Pharmaceuticals, Inc.
Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
M.D. Anderson Cancer Center
CHIP
Pfizer